Article references (19 references )


  1. AUA American new guidelines on prostate cancer screening. April 2009. http://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm. Accessed December 2012.

  2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003 Jan-Feb: 53(1):27-43. PubMed | Google Scholar

  3. National Cancer Institute. Prostate cancer screening. http://www.cancer.gov/cancertopics/pdq/screening/prostate/Patient. Accessed December 2012.

  4. US Preventive Services Task Force updates Prostate Cancer Screening recommendations. 2008. http://www.acponline.org/pressroom/pcancer.htm. Accessed December 2012.

  5. Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. Aug 2010; 11(8):725-32. PubMed | Google Scholar

  6. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. Mar 2009; 26(12): 360:1320-8. PubMed | Google Scholar

  7. Schroder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. Mar 2012; 15: 366(11):981-90. PubMed | Google Scholar

  8. Ogunbiyi JO, Shittu OB. Increased incidence of prostate cancer in Nigerians. J Natl Med Assoc. Mar 1999; 91(3):159-64. PubMed | Google Scholar

  9. Mohammed AZ, Edino ST, Ochicha O, Gwarzo AK, Samaila AA. Cancer in Nigeria: a 10-year analysis of the Kano cancer registry. Niger J Med. Jul-Aug 2008; 17(3):280-4. PubMed | Google Scholar

  10. Osegbe DN. Prostate cancer in Nigerians: facts and nonfacts. J Urol. Apr 1997; 157(4):1340-3. PubMed | Google Scholar

  11. Badmus TA, Adesunkanmi AR, Yusuf BM, et al. Burden of prostate cancer in southwestern Nigeria. Urology. Aug 2010; 76(2):412-6. PubMed | Google Scholar

  12. Fradet Y, Klotz L, Trachtenberg J, Zlotta A. The burden of prostate cancer in Canada. Can Urol Assoc J. Jun 2009; 3(suppl 2):S92-S100. PubMed | Google Scholar

  13. Odedina FT, Ogunbiyi JO, Ukoli FA. Roots of prostate cancer in African-American men. J Natl Med Assoc. Apr 2006; 98(4):539-43. PubMed | Google Scholar

  14. Odedina FT, Akinremi TO, Chinegwundoh F, et al. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009; 4 (Suppl 1):S2. PubMed | Google Scholar

  15. Ajape AA, Babata A, Abiola OO. Knowledge of prostate cancer screening among native African urban population in Nigeria. Nig Q J Hosp Med. Apr-Jun 2010; 20(2):94-6. PubMed | Google Scholar

  16. Ukoli F, Osime U, Akereyeni F, Okunzuwa O, Kittles R, Adams-Campbell L. Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Int J Urol. Jun 2003; 10(6):315-22. PubMed | Google Scholar

  17. Rabah DM, Arafa MA. Prostate cancer screening in a Saudi population: an explanatory trial study. Prostate Cancer Prostatic Dis. Jun 2010; 13(2):191-4. PubMed | Google Scholar

  18. Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med. Jun 2004; 38(6):732-44. PubMed | Google Scholar

  19. Abbiyesuku FM, Shittu OB, Oduwole OO, Osotimehin BO. Prostate specific antigen in the Nigerian African. Afr J Med Med Sci. Jun 2000; 29(2):97-100. PubMed | Google Scholar